BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1326 related articles for article (PubMed ID: 8982753)

  • 21. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B; Zeng T; Wu S; Sun H; Xiao N
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
    Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG
    Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A longitudinal study of changes in endometrial microvascular density in Norplant implant users.
    Hickey M; Simbar M; Young L; Markham R; Russell P; Fraser IS
    Contraception; 1999 Feb; 59(2):123-9. PubMed ID: 10361627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception.
    Runic R; Schatz F; Krey L; Demopoulos R; Thung S; Wan L; Lockwood CJ
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1983-8. PubMed ID: 9177417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal treatment for bleeding irregularities in Norplant implant users.
    Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
    Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphometric study of the human endometrium following continuous exposure to levonorgestrel released from vaginal rings during 90 days.
    Johannisson E; Brosens I; Cornillie F; Elder M; White J; Sheppard B; Hourihan H; d'Arcangues C; Belsey EM
    Contraception; 1991 Apr; 43(4):361-74. PubMed ID: 1906792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
    Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
    Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of the endometrial changes in Norplant users.
    Wan LS
    Ann N Y Acad Sci; 1997 Sep; 828():108-10. PubMed ID: 9329828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
    Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
    Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users.
    Marbaix E; Vekemans M; Galant C; Rigot V; Lemoine P; Dubois D; Picquet C; Henriet P; Twagirayezu P; Sufi S; Eeckhout Y; Courtoy PJ
    Hum Reprod; 2000 Aug; 15 Suppl 3():120-34. PubMed ID: 11041228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical study of endometrial microvascular basement membrane components in women using Norplant.
    Palmer JA; Lau TM; Hickey M; Simbah M; Rogers PA
    Hum Reprod; 1996 Oct; 11(10):2142-50. PubMed ID: 8943519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle.
    Critchley HO; Bailey DA; Au CL; Affandi B; Rogers PA
    Hum Reprod; 1993 Oct; 8(10):1632-9. PubMed ID: 8300819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The changes of sex steroid receptors and morphology in Norplant treated endometrium].
    Wang G; Zheng S; Fan Z
    Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):493-7. PubMed ID: 10806752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
    Brache V; Alvarez-Sanchez F; Faundes A; Tejada AS; Cochon L
    Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant implants.
    Alvarez F; Brache V; Tejada AS; Cochon L; Faundes A
    Contraception; 1998 Oct; 58(4):211-4. PubMed ID: 9866001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant implants.
    Faúndes A; Alvarez F; Brache V; Cochón L
    Hum Reprod; 1998 Jan; 13(1):188-91. PubMed ID: 9512255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
    Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
    Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menstrual bleeding patterns in Norplant-2 implant users.
    Biswas A; Leong WP; Ratnam SS; Viegas OA
    Contraception; 1996 Aug; 54(2):91-5. PubMed ID: 8842585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.